1Center of Urology & Nephrology, 324th Hospital of PLA, Chongqing 400020, China. shuu71@sina.com.cn
Prostate stem cell antigen (PSCA) shows promise as a biomarker for prostate, bladder, and pancreatic cancers, with higher sensitivity than PSA. Further research is needed to validate its diagnostic and therapeutic potential.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: